2.5. Hypertension and heart failure
2.5.6. Other medicines beneficial in heart failure
Total Formulary
DAPAGLIFLOZIN
Prescribing Notes:
Refer to the GGC Heart Failure treatment guideline (in development) for advice on initiation and monitoring.
For use in Chronic Kidney Disease, see section 7.5
EMPAGLIFLOZIN
Prescribing Notes:
Refer to the GGC Heart Failure treatment guideline (in development) for advice on initiation and monitoring.
TAFAMIDIS (Vyndaqel) (Capsule)
Restrictions:
Restricted to specialist use only in the treatment of wild-type and hereditary transthyretin amyloidosis in adults with cardiomyopathy (ATTR-CM).